1. Home
  2. ALTS vs AVTX Comparison

ALTS vs AVTX Comparison

Compare ALTS & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALTS
  • AVTX
  • Stock Information
  • Founded
  • ALTS 1976
  • AVTX 2011
  • Country
  • ALTS United States
  • AVTX United States
  • Employees
  • ALTS N/A
  • AVTX N/A
  • Industry
  • ALTS
  • AVTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALTS
  • AVTX Health Care
  • Exchange
  • ALTS NYSE
  • AVTX Nasdaq
  • Market Cap
  • ALTS 72.7M
  • AVTX 88.4M
  • IPO Year
  • ALTS N/A
  • AVTX 2015
  • Fundamental
  • Price
  • ALTS $6.90
  • AVTX $7.35
  • Analyst Decision
  • ALTS
  • AVTX Strong Buy
  • Analyst Count
  • ALTS 0
  • AVTX 4
  • Target Price
  • ALTS N/A
  • AVTX $33.00
  • AVG Volume (30 Days)
  • ALTS 233.7K
  • AVTX 55.8K
  • Earning Date
  • ALTS 04-07-2025
  • AVTX 03-28-2025
  • Dividend Yield
  • ALTS N/A
  • AVTX N/A
  • EPS Growth
  • ALTS N/A
  • AVTX N/A
  • EPS
  • ALTS N/A
  • AVTX N/A
  • Revenue
  • ALTS $7,110,000.00
  • AVTX $820,000.00
  • Revenue This Year
  • ALTS N/A
  • AVTX N/A
  • Revenue Next Year
  • ALTS N/A
  • AVTX N/A
  • P/E Ratio
  • ALTS N/A
  • AVTX N/A
  • Revenue Growth
  • ALTS N/A
  • AVTX N/A
  • 52 Week Low
  • ALTS $0.78
  • AVTX $4.18
  • 52 Week High
  • ALTS $7.09
  • AVTX $34.46
  • Technical
  • Relative Strength Index (RSI)
  • ALTS 62.80
  • AVTX 42.79
  • Support Level
  • ALTS $4.60
  • AVTX $7.42
  • Resistance Level
  • ALTS $6.64
  • AVTX $8.50
  • Average True Range (ATR)
  • ALTS 0.65
  • AVTX 0.64
  • MACD
  • ALTS 0.02
  • AVTX 0.02
  • Stochastic Oscillator
  • ALTS 98.29
  • AVTX 17.16

About ALTS ALT5 SIGMA CORPORATION

ALT5 Sigma Corp is a fintech company. It is providing next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment and safe-keeping of digital assets. The company product include ALT 5 Prime is an electronic over-the-counter trading platform and ALT 5 Pay crypto payment processor.

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

Share on Social Networks: